Facebook Pixel 'Deadly Risk' of Fat-Loss Drugs | Newsweek Europe – news – Lesen Sie diese Geschichte auf Magzter.com
Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

'Deadly Risk' of Fat-Loss Drugs

Newsweek Europe

|

March 22, 2024

Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts

- PANDORA DEWAN

'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

WEITERE GESCHICHTEN VON Newsweek Europe

Newsweek Europe

Newsweek Europe

JACK WHITEHALL

COMEDIAN JACK WHITEHALL IS TRADING PUNCHLINES FOR THE “GOOD TYPE OF NERVES” in the new series 'The Burbs.

time to read

2 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

Can Ken Martin Save the Democrats From Themselves?

The party may be winning special elections and polling strongly, yet members remain anxious. A year into his reign, the DNC chair is betting on organizing and infrastructure—not insiders—to turn momentum into power

time to read

16 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

OSCARS EMBRACE THE DARK SIDE

With record-breaking nods for Sinners, 2026 marks a shift toward horror. The Academy Awards may have finally gotten over its fear of the macabre

time to read

4 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

WHO WILL STRIKE GOLD AT THE ACADEMY AWARDS?

If you're looking to win your friends' pool, here are our favorites to take home the trophies

time to read

3 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

Strength in Numbers

When Japanese Prime Minister Sanae Takaichi dissolved parliament just three months into her premiership and called a snap election in January, it was widely seen as a high-risk gamble. Her Liberal Democratic Party had been weakened by scandal, coalition fractures and years of voter fatigue. A loss would almost certainly have ended her leadership. Instead, the bet produced one of the most decisive mandates in modern Japanese politics.

time to read

1 min

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

CAITRIONA BALFE

The actor reflects on the final season of Starz's epic historical drama Outlander, taking time to decompress after wrapping and how she decides what comes next

time to read

2 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

ONE OPINION AFTER ANOTHER

Two-time Oscar winner Sean Penn has always worn his politics on his sleeve. After gaining a sixth Academy Award nomination for One Battle After Another, the actor tells Newsweek about giving his statuette to Volodymyr Zelensky, how Nicolás Maduro should be in prison and why Donald Trump won in 2024

time to read

12 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

LOVE IN THE LINE OF FIRE

In Ukraine's front-line city of Kramatorsk, couples separated by war risk brief reunions as Russian forces close in

time to read

7 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

NEXT-DOOR ENABLER

How Beijing's carefully calibrated support has helped sustain Moscow as it fights Ukraine—without crossing key red lines

time to read

4 mins

February 27 - March 6, 2026

Newsweek Europe

Newsweek Europe

A WAR OF INCHES

The conflict between Kyiv and Moscow has become one of attrition, analysts say, with both sides paying a high price for small gains

time to read

7 mins

February 27 - March 6, 2026

Listen

Translate

Share

-
+

Change font size